Orexin Receptor Antagonists as Modulators of Threat Sensitivity in Individuals With Alcohol Use Disorder

NCT05656534 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

81

Enrollment

OTHER

Sponsor class

Conditions

Alcohol Use Disorder

Interventions

DRUG: Suvorexant
OTHER: Placebo

Sponsor

Ohio State University

Collaborators

[object Object]